Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Taxes: 2021-2022

Historic Change in Taxes for Cartesian Therapeutics (RNAC) over the last 2 years, with Dec 2022 value amounting to -$601,000.

  • Cartesian Therapeutics' Change in Taxes fell 102.03% to -$321,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$15.8 million, marking a year-over-year change of. This contributed to the annual value of -$601,000 for FY2022, which is 200.00% down from last year.
  • Per Cartesian Therapeutics' latest filing, its Change in Taxes stood at -$601,000 for FY2022, which was down 200.00% from $601,000 recorded in FY2021.
  • In the past 5 years, Cartesian Therapeutics' Change in Taxes ranged from a high of $601,000 in FY2021 and a low of -$601,000 during FY2022.
  • Its 2-year average for Change in Taxes is $0, with a median of $0 in 2021.
  • Data for Cartesian Therapeutics' Change in Taxes shows a maximum YoY crashed of 200.00% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Cartesian Therapeutics' Change in Taxes stood at $601,000 in 2021, then crashed by 200.00% to -$601,000 in 2022.